# Germany Nanobots Market > Germany Nanobots Market Research Report By Product Type (Nanomanipulator, Bio-Nanorobotics, Magnetically Guided Nanobots/Nanorobots) and By Application (Nano Medicine, Biomedical) -Forecast to 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 9.74% - **2024:** $ 469.2 Million - **2025:** $ 514.9 Million - **2035:** $ 1,304.9 Million - **Key Players:** Adept Technology (US), Nanosys (US), Zyvex Labs (US), Molecular Machines (DE), NanoComposix (US), Bionanotechnology (US), Nanoscale (US), Nanobot Medical (US) **Report ID:** MRFR/HC/53256-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/germany-nanobots-market-55020 --- ## Market Summary ## **Germany Nanobots Market Overview** As per MRFR analysis, the Germany Nanobots Market Size was estimated at 395 (USD Million) in 2023.The Germany Nanobots Market is expected to grow from 447.5(USD Million) in 2024 to 1,965 (USD Million) by 2035. The Germany Nanobots Market CAGR (growth rate) is expected to be around 14.397% during the forecast period (2025 - 2035)**.** **Key Germany Nanobots Market Trends Highlighted** Technological developments and an increasing focus on healthcare innovation are driving notable trends in the German nanobots market. The region has become a leader in nanotechnology research thanks to financing schemes and government initiatives that promote innovation in this area. The German healthcare industry is becoming more and more interested in the potential of nanobots to improve treatment efficacy, with a particular emphasis on precision medicine and targeted drug delivery. The creation of nanoscale systems that can carry medications straight to impacted cells, reducing side effects and enhancing patient outcomes, is one example of this. Additionally, there are a lot of untapped possibilities in the field of industrial nanobot applications. One important German industry, the automotive sector, is investigating the integration of nanobots for maintenance, repair, and even assembly procedures, which might revolutionize manufacturing efficiency. Applications in the environment are also growing since nanobots may be essential to remediation and pollution control plans. Interest in utilizing nanotechnology for environmental advantages is further fueled by Germany's dedication to sustainability. Collaboration between the commercial sector and academic institutions has sped up research and development in recent years. This pattern demonstrates an expanding innovation ecosystem in which academic institutions, research centers, and entrepreneurs collaborate to expand the capabilities of nanobots. Advances in nanobot technology can be effectively marketed thanks to Germany's strong intellectual property framework, which also promotes innovation protection. All things considered, these patterns suggest a thriving future for the German nanobots market, one marked by interdisciplinary cooperation and a close connection to the country's sustainability and health concerns. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Germany Nanobots Market Drivers** **Growing Demand for Advanced Healthcare Solutions** The Germany [Nanobots Market](../../../reports/nanobots-market-1301) is experiencing significant growth due to the increasing demand for advanced healthcare solutions. As the healthcare landscape evolves, there is a rising need for minimally invasive procedures, which nanobots can facilitate. According to a report by the Federal Ministry of Health in Germany, there has been a consistent annual increase of approximately 8 percent in the number of minimally invasive surgical procedures since 2023. This shift towards minimally invasive techniques is largely driven by patient preferences for reduced recovery times and lower surgical risks. Furthermore, leading healthcare organizations, such as Fresenius SE & Co. KGaA and Bayer AG, are investing heavily in the development of innovative healthcare technologies, including nanobots. This investment drives research and development initiatives that enhance the capabilities and applications of nanobots in medical procedures, thereby propelling market growth in Germany. **Increase in Chronic Diseases** The rise in the prevalence of chronic diseases in Germany is a crucial driver for the growth of the Germany Nanobots Market. Chronic conditions such as diabetes, cancer, and cardiovascular diseases are on the rise. According to the Robert Koch Institute, around 7 million individuals in Germany were diagnosed with diabetes in 2020, with projections indicating a steady rise in cases. With the increasing burden of these diseases, there is a significant demand for innovative solutions that can provide targeted therapies and real-time monitoring, areas where nanobots excel. Additionally, leading institutions in Germany, like the German Cancer Research Center, are actively exploring the use of nanobots for targeted drug delivery and cancer treatment, creating a burgeoning market opportunity. **Advancements in Nanotechnology Research** The remarkable advancements in nanotechnology research are fueling the growth of the Germany Nanobots Market. Germany is home to world-class research institutions such as the Max Planck Society and the Fraunhofer Society, which are at the forefront of nanotechnology research and development. These institutions have reported a 15% annual increase in research publications related to nanotechnology over the past decade, indicating the sector's dynamic growth. As innovations continue to emerge, the applications of nanobots in various fields – from medical diagnoses to environmental monitoring – are expanding. This surge in research is complemented by government funding initiatives, such as the German Federal Ministry of Education and Research's funding program, which allocated over 200 million Euros to support nanotechnology research in 2021. **Technological Innovations and Patents** Technological innovations in the field of nanobots are a significant driver for the Germany Nanobots Market. The number of patented nanobot technologies has surged, indicating a growing interest in this area. Data from the European Patent Office reveals that Germany filed around 1,200 patents related to nanotechnology and nanobots in 2022, reflecting a 20 percent increase compared to the previous year. This influx of patents represents valuable advancements that can enhance the functionality and applicability of nanobots across various industries, particularly healthcare. Leading companies like Siemens AG and BASF SE are investing in developing cutting-edge technologies, thereby fostering a competitive environment that drives further innovation and growth in the national market. **Germany Nanobots Market Segment Insights** **Nanobots Market Product Type Insights** The Germany Nanobots Market encompasses a diverse range of Product Types, creating distinct pathways for innovation and application within various sectors. Nanomanipulators play a crucial role in manipulating materials at the nanoscale, facilitating advancements in electronics, manufacturing, and medical applications. These devices are particularly significant in the precision engineering sector, where accurate manipulation can lead to improved outcomes in Research and Development processes. Bio-Nanorobotics is another vital category, focusing on the integration of nanobots within biological systems. This area is seeing considerable growth due to its applications in targeted drug delivery, diagnostics, and minimally invasive surgeries, where precision is essential for effective treatment outcomes. Magnetically Guided Nanobots and Nanorobots have also gained prominence, utilizing magnetic fields for navigation within the body, thus enhancing the effectiveness of therapeutic applications. This type has shown significant potential in cancer treatment, as these robots can precisely target tumor sites, minimizing damage to surrounding healthy tissues. Germany, known for its strong industrial base and robust Research and Development ecosystems, benefits greatly from these technological advancements in nanobot applications. The necessity for innovation in fields like healthcare and materials science is driving interest in these Product Types, leading to a highly competitive landscape focused on developing efficient, effective, and safe nanotechnology solutions. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Nanobots Market Application Insights** The Application segment of the Germany Nanobots Market is a critical area reflecting the technological advancements in various fields. Within this segment, NanoMedicine and Biomedical applications play significant roles. NanoMedicine focuses on using nanobots for tasks such as targeted drug delivery and cancer treatment, which are becoming increasingly relevant due to the rising incidence of chronic diseases. The advancements in nanostructures make treatments more efficient by reducing side effects and improving patient outcomes. In the Biomedical field, nanobots are employed for diagnostics and imaging, offering enhanced precision in medical assessments. The integration of these nanobots into healthcare contributes to Germany's reputation as a leader in innovation and healthcare technology. The consistent increase in Research and Development activities in Germany further highlights the potential growth in this segment, as more stakeholders recognize the benefits of nanotechnology in improving healthcare solutions. Overall, the significance of these applications drives the overall progress and evolution of the Germany Nanobots Market, marking it as a pivotal area within this growing industry. **Germany Nanobots Market Key Players and Competitive Insights** The Germany Nanobots Market is characterized by a vibrant competitive landscape, driven by technological advancements and a growing demand for innovative solutions across various sectors including healthcare, environmental remediation, and manufacturing. This market showcases a plethora of companies that specialize in the development and application of nanobots, which are miniature robots capable of performing tasks at the nanoscale. Competitive dynamics in this market are influenced by factors such as research and development capabilities, collaborations with academic institutions, and partnerships in the technology sector. As businesses strive to gain a competitive edge, a focus on enhancing product offerings while aligning with regulatory standards also plays a crucial role. The growing interest in nanotechnology has attracted considerable investment, thus propelling the market toward rapid growth and expansion. Zyvex Labs has established a significant presence in the Germany Nanobots Market by leveraging its extensive technological expertise and applying advanced scientific research in nanotechnology. The company is recognized for its commitment to innovation, which positions it as a leader in the development of nanobots. Zyvex Labs' strength lies in its ability to create highly efficient nanobots designed for specific applications such as drug delivery and targeted therapies, which have substantial implications in the medical field. Their focus on quality and precision has allowed them to carve out a niche within the German market, emphasizing the interoperability of their products with existing healthcare frameworks. Furthermore, Zyvex Labs continues to strengthen its market presence through collaborations and partnerships aimed at enhancing research outcomes and product utilization. Advanced Nano Products has carved its niche in the Germany Nanobots Market through the provision of cutting-edge nano-scale solutions tailored for various applications including agriculture, clean energy, and healthcare. The company benefits from a robust portfolio of key products and services that exemplify its commitment to advancing nanotechnology. Strengths of Advanced Nano Products include its strong emphasis on research and development which ensures continuous innovation and a diverse range of offerings that meet specific industry needs. The company has also engaged in several strategic mergers and acquisitions aimed at bolstering its capabilities and market reach in Germany. By focusing on sustainability and reliable nanobot technologies, Advanced Nano Products has effectively positioned itself as a formidable player in the German nanobots landscape, and its collaborative efforts with other industry stakeholders further enhance its competitive advantage. **Key Companies in the Germany Nanobots Market Include** - Zyvex Labs - Advanced Nano Products - Bionanoptech - Molecular NV - Cytogel Pharma - NanoComposix - Smart Planet Technologies - NanoDimension - Nanoscribe - Nanobiosym - Cardea Bio - Fraunhofer Institute - CytomX Therapeutics - Technion **Germany Nanobots****Market****Developments** In recent months, the Germany Nanobots Market has witnessed significant developments, particularly in collaborative efforts and advancements in technology. Companies like Zyvex Labs and NanoDimension are pushing the frontiers of nanotechnology with their innovative nanobots designed for various applications, including drug delivery and environmental monitoring. Furthermore, in a remarkable development in June 2023, Advanced Nano Products announced a strategic partnership with Fraunhofer Institute to enhance R&D capabilities in nanomedicine. There have also been notable increases in market valuations, with Nanoscribe reporting a substantial growth in demand for its 3D printing technology, leading to a broader adoption of nanobots in industrial applications. Additionally, within the last few years, in September 2022, Cytogel Pharma secured substantial funding to further its research in nanotechnology for therapeutic applications. Companies such as Bionanoptech and Nanobiosym have also marked their presence in the market, indicating a robust trend towards innovation and application in diverse fields. Overall, the dynamics of the Germany Nanobots Market are evolving rapidly with advancements in technology and strategic collaborations amongst key players. **Germany Nanobots Market Segmentation Insights** **Nanobots Market Product Type****Outlook** - Nanomanipulator - Bio-Nanorobotics - Magnetically Guided Nanobots/Nanorobots **Nanobots Market Application****Outlook** - NanoMedicine - Biomedical ## Market Drivers ### Regulatory Support for Nanotechnology The regulatory landscape in Germany is becoming increasingly supportive of nanotechnology, which is likely to foster growth in the nanobots market. The government has established frameworks to facilitate the safe development and commercialization of nanotechnology products. This regulatory support is crucial for instilling confidence among investors and manufacturers, encouraging them to explore nanobot applications in various sectors. As regulations evolve to accommodate advancements in nanotechnology, the market is expected to expand, potentially reaching a valuation of €800 million by 2026. This supportive environment is essential for the sustained growth of the nanobots market. ### Advancements in Nanotechnology Research Germany is recognized for its robust research and development in nanotechnology, which significantly influences the nanobots market. Academic institutions and research organizations are actively exploring new applications for nanobots, particularly in fields such as medicine and materials science. The government has allocated substantial funding to support nanotechnology initiatives, which is expected to enhance innovation and commercialization of nanobots. As a result, the market is likely to see a surge in new products and applications, potentially increasing its value to €1 billion by 2027. This environment of innovation is crucial for the growth of the nanobots market. ### Rising Demand for Targeted Drug Delivery The increasing prevalence of chronic diseases in Germany has led to a rising demand for targeted drug delivery systems. Nanobots, with their ability to navigate through the human body and deliver drugs precisely to affected areas, are becoming essential in modern healthcare. The nanobots market is expected to benefit from this trend, as healthcare providers seek innovative solutions to improve patient outcomes. According to recent estimates, the market for targeted drug delivery systems is projected to grow at a CAGR of 15% over the next five years. This growth is likely to drive investments in the nanobots market, as pharmaceutical companies look to integrate nanotechnology into their drug development processes. ### Increased Investment in Healthcare Technologies The German government and private sector are increasingly investing in healthcare technologies, which is positively impacting the nanobots market. With a focus on improving healthcare delivery and patient care, investments are being funneled into research and development of advanced medical technologies, including nanobots. In 2025, healthcare technology investments in Germany are projected to reach €5 billion, with a significant portion directed towards nanotechnology applications. This influx of capital is likely to accelerate the development and adoption of nanobots, making them a vital component of future healthcare solutions. ### Growing Awareness of Environmental Sustainability As environmental concerns continue to rise, there is a growing awareness in Germany regarding the potential of nanobots in addressing sustainability challenges. The nanobots market is poised to benefit from applications in environmental monitoring and remediation. For instance, nanobots can be utilized to detect pollutants and facilitate the cleanup of contaminated sites. The German government has set ambitious targets for reducing carbon emissions, which may drive the adoption of innovative technologies, including nanobots, to achieve these goals. This trend suggests a promising future for the nanobots market as it aligns with national sustainability objectives. ## Future Outlook The [Nanobots Market](https://www.marketresearchfuture.com/reports/nanobots-market-1301) is projected to grow at a 9.74% CAGR from 2025 to 2035, driven by advancements in healthcare, manufacturing, and environmental applications. **New opportunities:** - Development of targeted drug delivery systems for precision medicine. - Integration of nanobots in smart manufacturing processes for efficiency. - Creation of environmental monitoring solutions using nanobots for pollution control. By 2035, the nanobots market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Product Type: Nano Manipulators (Largest) vs. Bio-Nanorobotics (Fastest-Growing) In the Germany nanobots market, the segment of Nano Manipulators holds the largest market share due to its widespread application in precision tasks and fine manipulation at the nanoscale. This segment leverages advanced technology to enhance capabilities in sectors like manufacturing and healthcare, showcasing a strong market presence. On the other hand, Bio-Nanorobotics is rapidly emerging, driven by advancements in medical applications, particularly in drug delivery and diagnostic procedures. This growth is fueled by increasing research initiatives and collaboration between technology firms and healthcare providers. The growth trends for these product types signal a dynamic shift towards specialized applications in nanotechnology. The rising focus on personalized medicine and targeted therapies contributes significantly to the expansion of Bio-Nanorobotics, as stakeholders seek innovative solutions. Meanwhile, Nano Manipulators continue to benefit from the demand for automation and efficiency in manufacturing processes. Together, these segments indicate a robust competitive landscape, highlighting diverse opportunities for market players to explore across various specialties. Nano Manipulators (Dominant) vs. Magnetically Guided Nanobots (Emerging) The dominant segment, Nano Manipulators, is characterized by its high precision and versatility in performing intricate tasks at the nanoscale, making it integral to various industries such as electronics and biomedicine. Its established presence provides a competitive advantage, supported by a steady demand in automation and manufacturing sectors. Conversely, Magnetically Guided Nanobots represent an emerging segment with significant growth potential. These nanobots utilize magnetic fields for navigation, enabling targeted therapy in medical applications. Their development is driven by technological advancements and increased interest in non-invasive treatment methods. As the market continues to evolve, both segments are poised for growth, albeit with differing applications and strategic focuses. ### By Application: Nanomedicine (Largest) vs. Biomedical (Fastest-Growing) In the Germany nanobots market, the application segment is primarily dominated by nanomedicine, which holds significant market share due to its extensive use in drug delivery and targeted therapies. Biomedical applications are also gaining traction as they leverage nanobots for diagnostic and therapeutic purposes, contributing to advancements in personalized medicine and improving patient outcomes. The emergence of these technologies highlights the continuing evolution of nanobots with increasing adoption in medical settings. The growth trends within this segment are strongly driven by technological advancements and increasing investments in research and development. The rising prevalence of chronic diseases necessitates innovative solutions like nanobots, which offer improved efficacy and precision in treatment. Factors such as favorable regulatory frameworks and healthcare policies are also propelling the growth of biomedical applications, making them one of the fastest-growing areas in the market. Nanomedicine (Dominant) vs. Biomedical (Emerging) Nanomedicine is characterized by its application in drug delivery systems, enabling targeted therapies with minimized side effects, positioning it as a dominant force in the Germany nanobots market. This segment benefits from significant advancements in materials science, enhancing the functionality of nanobots in therapeutic applications. In contrast, the biomedical segment is emerging rapidly as it explores diagnostic and therapeutic innovations, driven by the integration of nanotechnology in healthcare. Biomedical applications focus on improving patient diagnostics through precision and efficiency, appealing to a broader audience as healthcare demands evolve. Both segments underscore an essential shift towards integrated healthcare solutions, fostering collaboration between technology and medicine. ### Nanobots Market Application Insights Nanobots Market Application Insights The Application segment of the Germany Nanobots Market is a critical area reflecting the technological advancements in various fields. Within this segment, NanoMedicine and Biomedical applications play significant roles. NanoMedicine focuses on using nanobots for tasks such as targeted drug delivery and cancer treatment, which are becoming increasingly relevant due to the rising incidence of chronic diseases. The advancements in nanostructures make treatments more efficient by reducing side effects and improving patient outcomes. In the Biomedical field, nanobots are employed for diagnostics and imaging, offering enhanced precision in medical assessments. The integration of these nanobots into healthcare contributes to Germany's reputation as a leader in innovation and healthcare technology. The consistent increase in Research and Development activities in Germany further highlights the potential growth in this segment, as more stakeholders recognize the benefits of nanotechnology in improving healthcare solutions. ## Competitive Benchmarking The nanobots market exhibits a dynamic competitive landscape, characterized by rapid technological advancements and increasing applications across various sectors, particularly in healthcare and environmental monitoring. Key growth drivers include the rising demand for precision medicine and the need for innovative solutions in drug delivery systems. Major players such as Molecular Machines (DE), Nanosys (US), and Zyvex Labs (US) are strategically positioned to leverage these trends. Molecular Machines (DE) focuses on developing advanced nanobots for targeted drug delivery, while Nanosys (US) emphasizes innovation in nanomaterials, enhancing the performance of nanobots. Zyvex Labs (US) is actively pursuing partnerships to expand its technological capabilities, thereby shaping a competitive environment that prioritizes innovation and collaboration.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain efficiency. The market structure appears moderately fragmented, with several players vying for market share. However, the collective influence of key players is significant, as they drive technological advancements and set industry standards. This competitive structure fosters an environment where innovation is paramount, compelling companies to continuously adapt and evolve their strategies. In October Molecular Machines (DE) announced a groundbreaking partnership with a leading pharmaceutical company to develop a new class of nanobots aimed at targeted cancer therapies. This collaboration is expected to enhance the efficacy of drug delivery systems, potentially revolutionizing treatment protocols. The strategic importance of this partnership lies in its potential to position Molecular Machines at the forefront of cancer treatment innovations, thereby increasing its market share and influence. In September Nanosys (US) unveiled a new line of nanobots designed for environmental monitoring, showcasing their commitment to sustainability. This initiative not only addresses growing environmental concerns but also aligns with global trends towards eco-friendly technologies. The strategic significance of this development is profound, as it allows Nanosys to diversify its product offerings and tap into new markets, enhancing its competitive edge. In August Zyvex Labs (US) secured a substantial investment to accelerate its research and development efforts in nanobot technology. This funding is aimed at expanding their capabilities in AI integration within nanobots, which could lead to smarter, more efficient systems. The strategic importance of this investment is evident, as it positions Zyvex Labs to lead in the integration of AI, a critical trend in the nanobots market. As of November current competitive trends are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing their technological capabilities. Looking ahead, competitive differentiation is likely to evolve, shifting from price-based competition to a focus on innovation, advanced technology, and supply chain reliability. This transition underscores the necessity for companies to invest in R&D and forge strategic partnerships to maintain a competitive advantage in the rapidly evolving nanobots market. ## Recent News & Developments In recent months, the Germany Nanobots Market has witnessed significant developments, particularly in collaborative efforts and advancements in technology. Companies like Zyvex Labs and NanoDimension are pushing the frontiers of nanotechnology with their innovative nanobots designed for various applications, including drug delivery and environmental monitoring. Furthermore, in a remarkable development in June 2023, Advanced Nano Products announced a strategic partnership with Fraunhofer Institute to enhance R&D capabilities in nanomedicine. There have also been notable increases in market valuations, with Nanoscribe reporting a substantial growth in demand for its 3D printing technology, leading to a broader adoption of nanobots in industrial applications. Additionally, within the last few years, in September 2022, Cytogel Pharma secured substantial funding to further its research in nanotechnology for therapeutic applications. Companies such as Bionanoptech and Nanobiosym have also marked their presence in the market, indicating a robust trend towards innovation and application in diverse fields. Overall, the dynamics of the Germany Nanobots Market are evolving rapidly with advancements in technology and strategic collaborations amongst key players. ## Report Scope | MARKET SIZE 2024 | 469.2(USD Million) | | --- | --- | | MARKET SIZE 2025 | 514.9(USD Million) | | MARKET SIZE 2035 | 1304.9(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.74% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Adept Technology (US), Nanosys (US), Zyvex Labs (US), Molecular Machines (DE), NanoComposix (US), Bionanotechnology (US), Nanoscale (US), Nanobot Medical (US) | | Segments Covered | Product Type, Application | | Key Market Opportunities | Advancements in nanotechnology drive innovative applications in healthcare and environmental remediation within the nanobots market. | | Key Market Dynamics | Rising demand for advanced healthcare solutions drives innovation and competition in the nanobots market. | | Countries Covered | Germany | ## Frequently Asked Questions **Q: What is the current valuation of the Germany nanobots market in 2024?** A: The overall market valuation was $469.2 Million in 2024. **Q: What is the projected market valuation for the Germany nanobots market by 2035?** A: The projected valuation for 2035 is $1304.9 Million. **Q: What is the expected CAGR for the Germany nanobots market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during this period is 9.74%. **Q: Which product types are included in the Germany nanobots market?** A: Key product types include Nano Manipulators, Bio-Nanorobotics, and Magnetically Guided Nanobots. **Q: What were the valuations for Nano Manipulators in 2024?** A: The valuation for Nano Manipulators ranged from $100.0 Million to $300.0 Million in 2024. **Q: How did the Bio-Nanorobotics segment perform in 2024?** A: The Bio-Nanorobotics segment had a valuation between $150.0 Million and $400.0 Million in 2024. **Q: What is the market size for Magnetically Guided Nanobots in 2024?** A: In 2024, the market size for Magnetically Guided Nanobots was between $120.0 Million and $350.0 Million. **Q: What applications are driving the Germany nanobots market?** A: Key applications include Nanomedicine and Biomedical, with others contributing as well. **Q: What were the valuations for Nanomedicine in 2024?** A: The valuation for Nanomedicine ranged from $100.0 Million to $300.0 Million in 2024. **Q: Who are the key players in the Germany nanobots market?** A: Key players include Adept Technology, Nanosys, Zyvex Labs, Molecular Machines, and others. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/germany-nanobots-market-55020*